Join

Compare · CGC vs PXMD

CGC vs PXMD

Side-by-side comparison of Canopy Growth Corporation (CGC) and PaxMedica Inc. (PXMD): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both CGC and PXMD operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
  • CGC carries a market cap of $2.86B.
  • CGC has hit the wire 1 time in the past 4 weeks while PXMD has been quiet.
  • CGC has more recent analyst coverage (19 ratings vs 0 for PXMD).
MetricCGCPXMD
Company
Canopy Growth Corporation
PaxMedica Inc.
Price
$1.18-2.88%
$0.72-3.73%
Market cap
$2.86B
-
1M return
-
-
1Y return
-
-
Industry
Medicinal Chemicals and Botanical Products
Medicinal Chemicals and Botanical Products
Exchange
NYSE
NASDAQ
IPO
2022
News (4w)
1
0
Recent ratings
19
0
CGC

Canopy Growth Corporation

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Bean & Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and NHL Alumni Association to examine the efficacy of CBD-based therapies as part of the mitigation of persistent post-concussion symptoms. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.